Topiramate Capsule, Extended Release
Product Images NDC 70710-1041

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70710-1041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 01)

Chemical structure of Topiramate, showing its molecular framework including sulfate and carbonyl functional groups clearly depicted.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 02)

A line graph showing cumulative rates for time to first seizure over 500 days for Topiramate doses of 50 mg/day and 400 mg/day. The y-axis represents cumulative rates, and the x-axis represents time in days. The graph compares seizure occurrence between the two dosing groups with a statistical significance p-value of 0.0002.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 03)

A bar graph comparing the proportion of patients by percentage reduction in seizure frequency from baseline. It shows data for two groups: placebo and Topiramate Extended-Release Capsules 200 mg/day, across seizure reduction ranges 0 to <25%, 25 to <50%, 50 to <75%, and 75 to 100%.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 04)

A bar graph displaying the change from baseline to double-blind phase in average monthly migraine period rate for placebo and three Topiramate dosage groups (50 mg/day, 100 mg/day, 200 mg/day) across two studies (Study 11 and Study 12). Error bars indicate the standard error. Significant reductions are noted at higher Topiramate doses, marked by asterisks for statistical significance.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 05)

Label for Topiramate Extended-Release Capsules, USP 25 mg, oral dosage form in capsule extended-release. Pack contains 30 capsules with once-daily dosing. Manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. Includes storage instructions, child-resistant packaging notice, and pharmacist dispensing guidance.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 06)

Label for Topiramate Extended-Release Capsules, USP 50 mg by Zydus Pharmaceuticals USA Inc. The label includes dosage form (extended-release capsules), strength (50 mg), quantity (30 capsules), and instructions for once-daily dosing. It has storage instructions, child-resistant packaging notice, pharmacist dispensing information, and manufacturer details (Zydus Lifesciences Ltd., India) and distributor (Zydus Pharmaceuticals USA, NJ).*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 07)

Topiramate Extended-Release Capsules USP 100 mg oral capsules package label by Zydus Pharmaceuticals USA Inc. The label indicates a 30-capsule count, prescription-only status, and includes storage instructions, dosage guidance, and manufacturer information. The NDC is 70710-1041-3.*

FDA Label Image

Image (2789fa8f Bb3b 4c35 A665 53efc476258d 08)

Label for Topiramate Extended-Release Capsules USP, 150 mg strength, in a 30-capsule package. The label notes once-daily dosing and that the product is prescription only. It includes storage instructions, manufacturer information for Zydus Lifesciences Ltd., and distributor details for Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Sl-200mg-30c (2789fa8f Bb3b 4c35 A665 53efc476258d 09)

Topiramate Extended-Release Capsules USP 200 mg label shows a white background with black and purple text. It includes dosing information, package size of 30 capsules, and directions indicating once-daily dosing. The label lists manufacturer Zydus Lifesciences Ltd., distributor Zydus Pharmaceuticals (USA) Inc., and safety storage instructions. The NDC number 70710-1043-3 is visible along the top.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.